Siemens Atellica™ CH Barbiturates (Brb)

Pays: Singapour

Langue: anglais

Source: HSA (Health Sciences Authority)

Disponible depuis:

SIEMENS HEALTHCARE PTE. LTD.

classe:

Class B IVD

Fabriqué par:

Siemens Healthcare Diagnostics Inc

Domaine thérapeutique:

Clinical toxicology

indications thérapeutiques:

The Atellica® CH Barbiturates (Brb) assay is a homogeneous enzyme immunoassay with a 200 ng/mL or 300 ng/mL cutoff. The Brb assay is for in vitro diagnostic use in the qualitative or semiquantitative analyses of barbiturates in human urine using the Atellica® Analyzers.

Descriptif du produit:

Device System Info:[Device with measuring function], [System or Procedure Pack]; Models: Atellica CH Barbiturates (Brb) - 11097507, Emit Calibrator/Control Level 0 - 10445406 (9A509UL), Emit Calibrator/Control Level 2 - 10445408 (9A549UL), Emit Calibrator/Control Level 3 - 10445409 (9A569UL), Emit Calibrator/Control Level 4 - 10445410 (9A589UL), Emit Calibrator/Control Level 5 - 10445411 (9A609UL)

Date de l'autorisation:

2017-12-11